These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 23932862)

  • 1. Optical coherence tomography analysis of strut coverage in biolimus- and sirolimus-eluting stents: 3-month and 12-month serial follow-up.
    Kim BK; Hong MK; Shin DH; Kim JS; Ko YG; Choi D; Jang Y
    Int J Cardiol; 2013 Oct; 168(5):4617-23. PubMed ID: 23932862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised comparison of strut coverage between Nobori biolimus-eluting and sirolimus-eluting stents: an optical coherence tomography analysis.
    Kim BK; Ha J; Mintz GS; Kim JS; Shin DH; Ko YG; Choi D; Jang Y; Hong MK
    EuroIntervention; 2014; 9(12):1389-97. PubMed ID: 24531309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial Optical Coherence Tomography Evaluation at 6, 12, and 24 Months After Biolimus A9-Eluting Biodegradable Polymer-Coated Stent Implantation.
    Konishi A; Shinke T; Otake H; Takaya T; Osue T; Kinutani H; Kuroda M; Takahashi H; Terashita D; Shite J; Hirata K
    Can J Cardiol; 2015 Aug; 31(8):980-8. PubMed ID: 26117623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between post-stent strut apposition and follow-up strut coverage assessed by a contour plot optical coherence tomography analysis.
    Kim JS; Ha J; Kim BK; Shin DH; Ko YG; Choi D; Jang Y; Hong MK
    JACC Cardiovasc Interv; 2014 Jun; 7(6):641-51. PubMed ID: 24835329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial randomized comparison of strut coverage of everolimus- and first-generation sirolimus-eluting stents.
    Kim JS; Kim JH; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Can J Cardiol; 2015 Jun; 31(6):723-30. PubMed ID: 25882337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biolimus-a9 eluting stent implantion for unprotected left main coronary artery stenosis: 9-month strut coverage as assessed by optical coherence tomography.
    Taglieri N; Ghetti G; Saia F; Moretti C; Gallo P; Dall'Ara G; Palmerini T; Marrozzini C; Rapezzi C; Marzocchi A
    J Invasive Cardiol; 2015 Feb; 27(2):70-7. PubMed ID: 25661757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Strut Coverage in Patients Receiving Drug-Eluting Stents and its Implications for Dual Antiplatelet Therapy: A Randomized Trial.
    Lee SY; Kim JS; Yoon HJ; Hur SH; Lee SG; Kim JW; Hong YJ; Kim KS; Choi SY; Shin DH; Nam CM; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    JACC Cardiovasc Imaging; 2018 Dec; 11(12):1810-1819. PubMed ID: 29454763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.
    Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR
    Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term coronary arterial response to biodegradable polymer biolimus-eluting stents in comparison with durable polymer sirolimus-eluting stents and bare-metal stents: five-year follow-up optical coherence tomography study.
    Kuramitsu S; Sonoda S; Yokoi H; Iwabuchi M; Nishizaki Y; Shinozaki T; Domei T; Hyodo M; Inoue K; Shirai S; Ando K; Nobuyoshi M
    Atherosclerosis; 2014 Nov; 237(1):23-9. PubMed ID: 25190308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents.
    Guagliumi G; Musumeci G; Sirbu V; Bezerra HG; Suzuki N; Fiocca L; Matiashvili A; Lortkipanidze N; Trivisonno A; Valsecchi O; Biondi-Zoccai G; Costa MA;
    JACC Cardiovasc Interv; 2010 May; 3(5):531-9. PubMed ID: 20488410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optical coherence tomography evaluation of late strut coverage patterns between first-generation drug-eluting stents and everolimus-eluting stent.
    Toledano Delgado FJ; Alvarez-Ossorio MP; de Lezo Cruz-Conde JS; Bellido FM; Romero Moreno MÁ; Fernández-Aceytuno AM; de Lezo Herrerosde Tejada JS; Pineda SO; Saint-Gerons JM; Pavlovic D
    Catheter Cardiovasc Interv; 2014 Nov; 84(5):720-6. PubMed ID: 24174291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial.
    Kim JS; Jang IK; Fan C; Kim TH; Kim JS; Park SM; Choi EY; Lee SH; Ko YG; Choi D; Hong MK; Jang Y
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1240-7. PubMed ID: 20129551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different serial changes in the neointimal condition of sirolimus-eluting stents and paclitaxel-eluting stents: an optical coherence tomographic study.
    Nakamura D; Lee Y; Yoshimura T; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y; Hara M; Sakata Y; Hamasaki T; Nishino M
    EuroIntervention; 2014 Dec; 10(8):924-33. PubMed ID: 24602858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized comparison of stent strut coverage following angiography- or optical coherence tomography-guided percutaneous coronary intervention.
    Kim JS; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Rev Esp Cardiol (Engl Ed); 2015 Mar; 68(3):190-7. PubMed ID: 25487222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term vascular healing in response to sirolimus- and paclitaxel-eluting stents: an optical coherence tomography study.
    Räber L; Baumgartner S; Garcia-Garcia HM; Kalesan B; Justiz J; Pilgrim T; Moschovitis A; Khattab AA; Buellesfeld L; Wenaweser P; Meier B; Serruys PW; Jüni P; Windecker S
    JACC Cardiovasc Interv; 2012 Sep; 5(9):946-57. PubMed ID: 22995882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of early strut coverage between zotarolimus- and everolimus-eluting stents using optical coherence tomography.
    Kim S; Kim JS; Shin DH; Kim BK; Ko YG; Choi D; Cho YK; Nam CW; Hur SH; Jang Y; Hong MK
    Am J Cardiol; 2013 Jan; 111(1):1-5. PubMed ID: 23040589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of High-Dose Statin Therapy on Drug-Eluting Stent Strut Coverage.
    Kim JS; Kim JH; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2460-7. PubMed ID: 26359512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of different stent alloys on human vascular response to everolimus-eluting stent: an optical coherence tomography study: the OCTEVEREST.
    Guagliumi G; Capodanno D; Ikejima H; Bezerra HG; Sirbu V; Musumeci G; Fiocca L; Lortkipanidze N; Vassileva A; Tahara S; Valsecchi O; Costa MA
    Catheter Cardiovasc Interv; 2013 Feb; 81(3):510-8. PubMed ID: 22431208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neointimal coverage on drug-eluting stent struts crossing side-branch vessels using optical coherence tomography.
    Her AY; Lee BK; Shim JM; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Am J Cardiol; 2010 Jun; 105(11):1565-9. PubMed ID: 20494663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.
    Fujino Y; Attizzani GF; Bezerra HG; Wang W; Tahara S; Yamamoto H; Chamie D; Kanaya T; Mehanna E; Takagi K; Nakamura S; Costa MA
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1035-45. PubMed ID: 24156964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.